Search Results

1 - 10 of 553 items :

  • pharmacokinetics x
Clear All
Pharmacokinetics Of Zinc In Broiler Chickens After Single Intraingluvial Administration With Zinc Aspartate

.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for PC. Stuttgart, Jena, New York: Gustav Fisher; 1993. 18. Baggot DJ. The Physiological Basis of Veterinary Clinical Pharmacology. Oxford (UK): Blackwell Science Ltd; 2001. 19. Gibaldi M, Perrier D. Pharmacokinetics, Revised and Expanded. 2nd ed. Swarbrick J, editor. New York: Informa Healthcare Inc; 2007. 20. Yamaoka K, Nakagawa T, Uno T. Application of Akaike’s Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6:166-75. 21. Ivanova

Open access
Pharmacokinetics of Ciprofloxacin in Broiler Chickens After Single Intravenous and Intraingluvial Administration

). Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Veterinary Quarterly 10, 156-163. PMid:3176294 7. Walker, R.D., Stein, G.E., Hauptman, J.G., MacDonald, K.H., Budsberg, S.C., Rosser, E.J.Jr. (1990). Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs. American Journal of Veterinary Research 51, 896-900. 8. Parikh, V., Shivprakash, K., Patel, D., Gandhi, T

Open access
Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits

derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. Eur J Med Chem   36 : 375-388. Jorenby D, Hays J, Rigotti N, Azoulay S, Watsky E, Williams K, Billing C, Gong J and Reeves K. (2006). Efficacy of varenicline, an α 4 β 2 -nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial. JAMA   296 : 56-63. Klocking H, Richter M, and Damm G. (1980). Pharmacokinetic studies with 3 Hcytisine. Arch Toxicol

Open access
Pharmacokinetic Behavior of Marbofloxacin in Plasma from Chickens at Different Seasons

., Wang, L., Shen, X., Gu, X., Zeng, D., Zeng, Z. (2013). Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli. J. Vet. Pharmacol. Ther. 36, 511-515. PMid:23550715 5. El-Komy, A., Attia, T., El Latif, A., Fathy, H. (2016). Bioavailability pharmacokinetics and residues of marbofloxacin in normal and E. coli infected broiler chicken. In. J. Pharmacol. Tox. 2 (4): 144-149. 6. Huang, X., Chen, Z., Zhang, S., Zeng, Z. (2003). Influence of

Open access
Pharmacokinetics of Doxycycline in Ducks with Steatosis due to Force-feeding

REFERENCES 1. Pijpers, A., Van Klingeren, B., Schoevers, E.J., Verheijden, J.H.M., Van Miert, A.S. (1989). In vitro activity of five tetracyclines and some other antimicrobial agents four porcine respiratory tract pathogens. J. Vet. Pharmacol. Ther. 12, 267–276. PMid:2810475 2. Anadón, A., Martínez-Larra-aga, M.R., Diaz, M.J., Bringas, P., Fernandez, M.C., Fernandez-Cruz, M.L., Iturbe, J., Martínez, M.A. (1994). Pharmacokinetics of doxycycline in broiler chickens. Avian Pathol. 23, 79-90. http

Open access
The Statistical Analysis of Pharmacokinetic Parameters in the Context of Bioequivalence Testing of Two Anthelmintic Formulas Based on Ivermectine and Triclabendazole in Sheep

References 1. Barrera B, Otero JA, Egido E et al. The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP. Antimicrob Agents Chemother 2012; 56(7): 3535-3543. 2. Halferty L, Brennan GP, Trudgett A, Hoey L, Fairweather I. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Vet Parasitol 2009; 159:126–138. 3. González Canga A, Sahagún Prieto AM, José Diez Liébana M, Martínez NF, Vega MS, Vieitez JJ. The pharmacokinetics and metabolism of ivermectin in domestic animal

Open access
Comparative Study of the Pharmacokinetics of Inorganic and Organic Iron Compounds in Broiler Chickens

References 1. Geisser, P., Burckhardt, S. (2011). The Pharmacokinetics and Pharmacodynamics of Iron preparations. Pharmaceutics, 3(1): 12-33. 2. Egli, A. K., Franstad, T., Gramingen, D. (1998). The effect of per oral administration of aminoacid chelated iron to pregnant sows in prevention sow and piglet anemia. Acta Veterinaria Scandinavica 39(1): 77-87. 3. Andrews, N. C. (1999). Disorders of iron metabolism. The New England Journal of Medicine 341, 1986-1995. 4. Kalantaz-Zadeh, K. E., Steja, E

Open access
Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics

, C. A. Martinusso, C. M. Takiya, A. J. Silva, J. F. Ornellas, P. R. Elias, M. Leite, Jr. and L. R. Cardoso, Fructose-1,6-diphosphate as a protective agent for experimental ischemic acute renal failure, Kidney Int. 69 (2006) 68-72; DOI: 10.1038/ 10. K. Xu and J. L. Stringer, Pharmacokinetics of fructose-1, 6-diphosphate after intraperitoneal and oral administration to adult rats, Pharmacol. Res. 57 (2008) 234-238; DOI 10.1016/j.phrs.2008.01.008. 11. S. Drabant, I. Klebovich, B. Gachalyi, G. Renczes and C. Farsang, Role

Open access
Changes in Some Pharmacokinetics Parameters of Chloroquine by Gnetum Africana

chloroquine sulphate and aqueous extract of Azadirachta indica A Juss (Meliaceae) in rabbits. Acta Pharmaceutica. 2003;53(4):305-11. 8. O’Brien D, Haddad AR. Consulting patients on drug-food interactions. U. S. Pharmacist. 2002;22(6). 9. Eseyin OA, Edoho EJ, Igboasoiyi AC, Nwadiukwu E, Ekpo A. Effects of the leaf extract of Telfairia occidentalis on the pharmacokinetic of chloroquine. International Journal of Biological Chemistry. 2007;1(4):256-260. 10. Igboasoiyi AC, Eseyin OA, Udoma NF. The effect of ethanolic extract of

Open access
Pharmacokinetic comparisons of S-oxiracetam and R-oxiracetam in beagle dogs

-term memory, Proc. Natl. Acad. Sci. USA 91 (1994) 2041–2045. 4. C. Mondadori, H. J. Möbius and J. Borkowski, The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory, Behav. Brain Res . 77 (1996) 223–225. 5. W. H. Brooks, W. C. Guida and K. G. Daniel, The significance of chirality in drug design and development, Curr. Top. Med. Chem . 11 (2011) 760–770; DOI: 10.2174/156802611795165098. 6. A. J. Hutt, Chirality and pharmacokinetics: an area of neglected dimensionality, Drug Metabol. Drug

Open access